NATCO PHARMA LTD.
Latest filings
- Natco Pharma allots 17.06 million rights shares at ₹750 each · Corporate Actions
- Trading window closed for results and briefly reopened for rights allotment · Compliance
- Natco Pharma Rights Issue closes today, size up to Rs 1,279 cr · Corporate Actions
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹3,485 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from NATCO PHARMA LTD.'s filed financials and exchange disclosures
What does NATCO PHARMA LTD. do?
NATCO PHARMA LTD. is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol NATCOPHARM.
Is NATCO PHARMA LTD. profitable?
Yes. Over the trailing twelve months NATCO PHARMA LTD. reported a net profit of ₹1,145 Cr on revenue of ₹3,485 Cr.
Does NATCO PHARMA LTD. pay a dividend?
Yes. The dividend yield is 0.64% at the current price. It paid out 6% of its profit as dividend in FY26.
Is NATCO PHARMA LTD. debt-free?
No. It reported borrowings of ₹706 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹508 Cr after cash. Debt stands at 0.08× equity. That is lower than 56% of its 166 Pharmaceuticals peers.
Is NATCO PHARMA LTD. expensive compared with its peers?
On trailing P/E, NATCO PHARMA LTD. ranks 29 of 158 in Pharmaceuticals — cheaper than 82% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the NATCO PHARMA LTD. share price move in a day?
On a typical session NATCO PHARMA LTD. moves 1.13% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track NATCO PHARMA LTD.'s announcements?
Every NSE and BSE filing by NATCO PHARMA LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.